Paola Lanza
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology.
Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: October 30, 2018
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Journal: Clinical epigenetics
Published: August 07, 2018
Telocytes as possible precursors of PDGFRA-mutant gastrointestinal mesenchymal tumors-rejoinder.
Journal: Human pathology
Published: July 24, 2018
Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTs.
Journal: Journal of cellular and molecular medicine
Published: April 08, 2018
Telocytes as possible precursors of PDGFRA-mutant gastrointestinal mesenchymal tumors.
Journal: Human pathology
Published: March 06, 2018
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer.
Journal: In vivo (Athens, Greece)
Published: July 03, 2017
PDGFRA-mutant syndrome.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 16, 2015
Antioxidant and anti-inflammatory effects of selected natural compounds contained in a dietary supplement on two human immortalized keratinocyte lines.
Journal: BioMed research international
Published: June 27, 2014
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: a cytohistologic institutional experience.
Journal: Cancer cytopathology
Published: November 27, 2013
Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells.
Journal: Histology and histopathology
Published: April 11, 2013
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma.
Journal: Histology and histopathology
Published: March 16, 2012
Last Updated: 09/26/2026